SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001551986-20-000124
Filing Date
2020-05-04
Accepted
2020-05-04 19:15:34
Documents
2
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_158863411658622.html 3  
1 FORM 3 wf-form3_158863411658622.xml 3 4831
2 POA ORBIMED 2020 ex-24.htm EX-24 3377
  Complete submission text file 0001551986-20-000124.txt   10578
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
INNOVATE BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022-4629
Business Address 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR HERZLIYA L3 46766 212-739-6400
OrbiMed Israel GP Ltd. (Reporting) CIK: 0001569590 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37797 | Film No.: 20846401

Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 1022-4629
Business Address 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR HERZLIYA L3 46766 212-739-6400
OrbiMed Israel BioFund GP Limited Partnership (Reporting) CIK: 0001569821 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37797 | Film No.: 20846402